SynthesisCancer treatment reviews2023

Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials.

Giovanni Maria Iannantuono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.